JP MORGAN/PUT/BECTON DICKINSON AND CO./235/0.1/20.09.24 Share Price

Warrant

DE000JK1PND9

Real-time Bid/Ask 08:40:09 27/06/2024 BST
1.48 EUR / 1.57 EUR +15.53% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./235/0.1/20.09.24
Current month-29.41%
1 month-20.96%
Date Price Change
25/06/24 1.32 +7.32%
24/06/24 1.23 -3.91%
21/06/24 1.28 -11.72%
20/06/24 1.45 -2.03%
19/06/24 1.48 -1.99%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 11:09 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JK1PND
ISINDE000JK1PND9
Date issued 25/01/2024
Strike 235 $
Maturity 20/09/2024 (86 Days)
Parity 10 : 1
Emission price 1.18
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.25
Lowest since issue 1.23
Delta-0.49x
Omega 6.942
Premium5.53x
Gearing14.3x
Moneyness 1.015
Difference Strike 3.38 $
Difference Strike %+1.44%
Spread 0.09
Spread %5.77%
Theoretical value 1.515
Implied Volatility 34.42 %
Total Loss Probability 45.21 %
Intrinsic value 0.3161
Present value 1.199
Break even 218.80 €
Theta-0.05x
Vega0.04x
Rho-0.02x

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
231.6 USD
Average target price
279.2 USD
Spread / Average Target
+20.54%
Consensus